CIK: 0001193586 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 15, 2023
Total Value ($000): $299,804 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCTY | Paylocity Holding Corporation | 593,200 | $115,235 | 38.4% | $27.51 | +680.8% | Common | 70438V106 |
| RMNI | Rimini Street, Inc. | 23,565,433 | $89,784 | 29.9% | $8.44 | -47.4% | Common | 76674Q107 |
| — | Vacasa, Inc. | 18,764,501 | $23,643 | 7.9% | $6.75 | — | Common- Class A | 91854V107 |
| QTWO | Q2 Holdings, Inc. | 777,562 | $20,893 | 7.0% | $19.72 | +41.8% | Common | 74736L109 |
| — | Icosavax, Inc. | 2,475,599 | $19,656 | 6.6% | $26.63 | — | Common | 45114M109 |
| — | Fusion Pharmaceuticals, Inc. | 2,947,809 | $9,286 | 3.1% | $15.72 | — | Common | 36118A100 |
| GTLB | GitLab, Inc. | 161,488 | $7,338 | 2.4% | $51.95 | -13.1% | Common- Class A | 37637K108 |
| TDG | TransDigm Group Incorporated | 9,289 | $5,849 | 2.0% | $503.62 | 0.0% | Common | 893641100 |
| CRVS | Corvus Pharmaceuticals, Inc. | 3,275,616 | $2,784 | 0.9% | $13.47 | -93.4% | Common | 221015100 |
| — | Aptinyx, Inc. | 5,395,996 | $1,563 | 0.5% | $16.86 | — | Common | 03836N103 |
| ACLX | Arcellx, Inc. | 38,544 | $1,194 | 0.4% | $22.94 | 0.0% | Common | 03940C100 |
| NU | Nu Holdings Ltd | 286,145 | $1,165 | 0.4% | $4.35 | 0.0% | Class A | G6683N103 |
| AMPL | Amplitude, Inc. | 41,440 | $501 | 0.2% | $14.16 | 0.0% | Common- Class A | 03213A104 |
| CFLT | Confluent, Inc. | 20,396 | $454 | 0.2% | $23.17 | 0.0% | Common-Class A | 20717M103 |
| LZ | LegalZoom.com, Inc. | 45,234 | $350 | 0.1% | $8.68 | 0.0% | Common | 52466B103 |
| IONQ | IonQ, Inc. | 31,629 | $109 | 0.0% | $4.83 | 0.0% | Common | 46222L108 |